I Want to See

search icon

I Want to See

Cardiovascular monitoring for people with cardiovascular disease and schizophrenia

Cardiovascular disease is the leading cause of premature death among people with schizophrenia. Some atypical antipsychotics increase total and low-density lipoprotein and decrease high-density lipoprotein, thereby increasing the risk of coronary heart disease. Although adults with schizophrenia are more likely than those without schizophrenia to have higher levels of blood cholesterol, they are less likely to receive common treatments, such as statins.

Patient population: People 18–64 years of age with schizophrenia and cardiovascular disease.

Quality Goal: Ensure patients have a low-density lipoprotein cholesterol (LDL-C) test every year.

What can you do for your patients with cardiovascular disease and schizophrenia?

  • Review medical records and ensure patients are tested.
  • Schedule appointments in advance, and send reminders to patients to keep their appointments.
  • Stay in contact with your patient’s care coordinator or case worker; they can help remind your patient about appointments.

Provider Resources

Patient Resources

24/7 Crisis Line

Let your patients know that they can get confidential help for mental health emergencies by calling
855-CRISIS-1 or 855-274-7471

Behavioral Health Consultation and Referral Line

Speak with an expert M-F 9-5 (ET)